ICER attributed such denials to cost concerns: supporting these new therapies (even at net prices) creates unprecedented budget impact, and some payers have explicitly chosen not to cover them for weight-loss ( [27] ) ( [36] )
Sai, B., Rao, N., Ramya, M., Sujana, S
Many women who adopt healthier eating and activity habits during tirzepatide treatment sustain significant weight loss even after stopping
The onset of perimenopause is largely influenced by age, as hormonal reserves naturally decline over time
Common side effects of tirzepatide include nausea, constipation, and fatigue, while rare but serious risks include hypoglycemia, pancreatitis, and kidney or gallbladder issues
Mitochondrial interactome quantitation reveals structural changes in metabolic machinery in the failing murine heart